DEPRESSION AND COGNITIVE DISTURBANCES: EXPERIENCE OF VORTIOXETINE USE IN NEUROLOGIC PRACTICE
The article provides an experience of use of the new antidepressant with the precognitive action – Vortioxetine. High therapy compliance was demonstrated. The drug is effective in relief of depression, improves cognitive functions in neurologic patients and presumably has pain-killing action.
Main Author: | Y. E. Azimova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2017-07-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1911 |
Similar Items
-
Experience with vortioxetine in the treatment of post-stroke depression
by: I. A. Strelnikova, et al.
Published: (2020-02-01) -
Efficacy of vortioxetine monotherapy compared with combined therapy vortioxetine and olanzapine in the treatment of major depression – first results
by: Oppa M., et al.
Published: (2017-09-01) -
Vortioxetine for Cognitive Enhancement in Major Depression: From Animal Models to Clinical Research
by: Djamila Bennabi, et al.
Published: (2019-11-01) -
The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease
by: I. V. Miliukhina
Published: (2020-10-01) -
Major depression with musical obsession treated with vortioxetine: a case report
by: Reiji Yoshimura, et al.
Published: (2021-03-01)